Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA.

Zhang J, Li G, Liu X, Wang Z, Liu W, Ye X.

J Gen Virol. 2009 Nov;90(Pt 11):2751-8. doi: 10.1099/vir.0.014316-0. Epub 2009 Aug 5.

PMID:
19656971
2.

Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

Beebe DP, Schreiber RD, Cooper NR.

J Immunol. 1983 Mar;130(3):1317-22.

PMID:
6822737
3.

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z.

J Infect Dis. 2009 Dec 15;200(12):1874-83. doi: 10.1086/648405.

PMID:
19909080
4.

Influenza A virus matrix protein 1 interacts with hTFIIIC102-s, a short isoform of the polypeptide 3 subunit of human general transcription factor IIIC.

Huang S, Chen J, Wang H, Sun B, Wang H, Zhang Z, Zhang X, Chen Z.

Arch Virol. 2009;154(7):1101-10. doi: 10.1007/s00705-009-0416-7. Epub 2009 Jun 12.

PMID:
19521658
5.

Interaction of influenza A virus M1 matrix protein with caspases.

Zhirnov OP, Ksenofontov AL, Kuzmina SG, Klenk HD.

Biochemistry (Mosc). 2002 May;67(5):534-9.

6.

Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication.

Liu X, Sun L, Yu M, Wang Z, Xu C, Xue Q, Zhang K, Ye X, Kitamura Y, Liu W.

Cell Microbiol. 2009 May;11(5):730-41. doi: 10.1111/j.1462-5822.2009.01286.x. Epub 2009 Jan 15.

PMID:
19207730
7.
8.

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.

Jayasekera JP, Moseman EA, Carroll MC.

J Virol. 2007 Apr;81(7):3487-94. Epub 2007 Jan 3.

9.

Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle.

Watanabe K, Fuse T, Asano I, Tsukahara F, Maru Y, Nagata K, Kitazato K, Kobayashi N.

FEBS Lett. 2006 Oct 16;580(24):5785-90. Epub 2006 Sep 27.

10.

Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y.

J Immunol. 2007 Feb 15;178(4):2448-57.

11.

Interaction of influenza A virus matrix protein with RACK1 is required for virus release.

Demirov D, Gabriel G, Schneider C, Hohenberg H, Ludwig S.

Cell Microbiol. 2012 May;14(5):774-89. doi: 10.1111/j.1462-5822.2012.01759.x. Epub 2012 Mar 6.

PMID:
22289149
12.

Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.

Rattan A, Pawar SD, Nawadkar R, Kulkarni N, Lal G, Mullick J, Sahu A.

PLoS Pathog. 2017 Mar 16;13(3):e1006248. doi: 10.1371/journal.ppat.1006248. eCollection 2017 Mar.

13.

[Effects of yin qiaojiedu soft capsule on influenza virus load and M1 expression in mice].

Liu Y, Shi YJ, Shi H, Zhong JY, Liu FZ, Gao YJ, Jin YH, Guo SS, Cui XL.

Yao Xue Xue Bao. 2011 Jun;46(6):650-5. Chinese.

PMID:
21882524
14.

Host Cellular Protein TRAPPC6AΔ Interacts with Influenza A Virus M2 Protein and Regulates Viral Propagation by Modulating M2 Trafficking.

Zhu P, Liang L, Shao X, Luo W, Jiang S, Zhao Q, Sun N, Zhao Y, Li J, Wang J, Zhou Y, Zhang J, Wang G, Jiang L, Chen H, Li C.

J Virol. 2016 Dec 16;91(1). pii: e01757-16. Print 2017 Jan 1.

15.

Membrane interaction of influenza virus M1 protein.

Ruigrok RW, Barge A, Durrer P, Brunner J, Ma K, Whittaker GR.

Virology. 2000 Feb 15;267(2):289-98.

16.

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.

Vaccine. 2009 Nov 5;27(47):6512-21. doi: 10.1016/j.vaccine.2009.08.053. Epub 2009 Sep 1.

PMID:
19729082
17.

Typing of human and animal strains of influenza virus with conserved signature peptides of matrix M1 protein by high resolution mass spectrometry.

Schwahn AB, Wong JW, Downard KM.

J Virol Methods. 2010 May;165(2):178-85. doi: 10.1016/j.jviromet.2010.01.015. Epub 2010 Feb 1.

PMID:
20117137
18.

In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein.

Baudin F, Petit I, Weissenhorn W, Ruigrok RW.

Virology. 2001 Mar 1;281(1):102-8.

19.

Influenza A virus M1 protein structure probed by in situ limited proteolysis with bromelain.

Kordyukova LV, Serebryakova MV, Polyakov VY, Ovchinnikova TV, Smirnova YA, Fedorova NV, Baratova LA.

Protein Pept Lett. 2008;15(9):922-30.

PMID:
18991768
20.

Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components.

Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W.

Virology. 2006 Sep 1;352(2):418-26. Epub 2006 Jun 14.

Supplemental Content

Support Center